Literature DB >> 31271061

MALDI-TOF mass spectrometry-based direct-on-target microdroplet growth assay: a novel assay for susceptibility testing and beyond.

Ioannis K Neonakis1, Demetrios A Spandidos2.   

Abstract

Keywords:  MALDI-TOF mass spectrometry; antimicrobial susceptibility testing; direct-on-target microdroplet growth assay; minimum inhibitory concentration; multidrug resistant microorganisms

Mesh：

Substances：

Year:  2019        PMID： 31271061     DOI： 10.2217/fmb-2019-0106

Source DB:  PubMed          Journal:  Future Microbiol        ISSN： 1746-0913            Impact factor:   3.165


× No keyword cloud information.
  5 in total

Review 1.  Detection of carbapenemase producers by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF MS).

Authors:  Ioannis K Neonakis; Demetrios A Spandidos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-06-28       Impact factor: 3.267

2.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Antimicrobial Susceptibility Testing.

Authors:  Evgeny A Idelevich; Karsten Becker
Journal:  J Clin Microbiol       Date:  2021-06-16       Impact factor: 5.948

Review 3.  Direct-on-Target Microdroplet Growth Assay Applications for Clinical Antimicrobial Susceptibility Testing.

Authors:  Rongrong Li; Hao Tang; Huaming Xu; Yingli Ren; Shujin Li; Jilu Shen
Journal:  Infect Drug Resist       Date:  2021-04-14       Impact factor: 4.003

4.  Direct-on-Target Microdroplet Growth Assay for Detection of Bacterial Resistance in Positive Blood Cultures.

Authors:  Hao Tang; Rongrong Li; Huaming Xu; Guoping Lu; Zhen Liu; Wensu Yang; Zhaoxin Xia; Yi Zhu; Jilu Shen
Journal:  Infect Drug Resist       Date:  2021-11-06       Impact factor: 4.003

5.  Rapid Identification and Drug Sensitivity Test to Urinary Tract Infection Pathogens by DOT-MGA.

Authors:  Zhen Liu; Hao Tang; Huaming Xu; Guoping Lu; Wensu Yang; Zhaoxin Xia; Yi Zhu; Shenwang Ni; Wanqi Men; Jilu Shen
Journal:  Infect Drug Resist       Date:  2022-03-31       Impact factor: 4.003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.